French feel optimistic over biotech future:
This article was originally published in Clinica
Executive Summary
The French biotech industry association, France Biotech, says it is encouraged by recent statements by President Jacques Chirac, supporting the creation of a favourable environment for biotechnology companies. In particular, it welcomes the prospect of a free enterprise zone for young technology companies. Dr Philippe Pouletty, president of the association, says that the Plan Biotech 2002 approved recently by the French government (see Clinica No 981, p 4) is a "significant first step", but that a five-year plan is needed for France to reach its objective of being in a leadership position in Europe by 2007.
You may also be interested in...
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.